Definium Therapeutics, Inc. · NASDAQ:DFTX
Karlin Daniel received 100,000 Definium Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 12, 2026 · Filed Aug 12, 2026
On Aug 12, 2026, Karlin Daniel (Chief Medical Officer) received 100,000 Definium Therapeutics, Inc. shares as an award, leaving 603,282 shares. Filed Aug 12, 2026 (Form 4).
- Awarded
- 100,000 shares
- Holding after
- 603,282 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Shares | Award | 100,000 | 603,282 | Direct |
Source
Related
- Definium Therapeutics, Inc.
- Karlin Daniel
- Definium Therapeutics, Inc. shareholders
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Karlin Daniel · Sep 14, 2026
- Form 4 · Karlin Daniel · Jun 26, 2026
- Form 4 · Karlin Daniel · Jun 22, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026
- Form 4 · Krebs Andreas · Sep 18, 2026